Positive outcome of the pivotal Phase III study with PQ Grass 27600 SU, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine (MCT) and Monophosphoryl Lipid A (MPL) as adjuvant system

The requested reference [5597433d0284f28280b8d9a275406fd5e2247c46] no longer exists in our database. It has been replaced by the current reference: [6d67ac4232ca882b9e7e8bfd75d8ef6eb59c0c93]

Authors
Category Primary study
ConferenceAllergologie
Year 2024
This article has no abstract
Epistemonikos ID: 7a45960280a332d6838b0b0160325da1a4da61fc
First added on: Apr 30, 2026